ArticleSmall science2024
Reactive Oxygen Species-Associated Chiral Nanoarchitectures for Bioscience.
Article in Small science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Guides for Developing Hundreds of Novel Chiral MXenes and MBenes Nanosheets/Quantum Dots for Next-Generation Chiral Engineered Biomaterials Applications.Advanced healthcare materials · 2025Review
- Ophthalmic Tethered Gold Yarnball-Mediated Retained Drug Delivery for Eye Fundus Disease Treatment.Small science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chirality is a common occurrence in nature and forms a critical basis for life. The unique optical activity of chiral nanomaterials plays an important role in the nanobiology field, particularly in the regulation of reactive oxygen species (ROS), both in cells and in vivo. By regulating ROS, chiral nanomaterials can achieve numerous biological effects. Herein, progression in the application of chiral nanomaterials in the field of bioscience is introduced. First, the strategies used to construct different types of ROS-related chiral nanomaterials are introduced. Then, the biological effects that can be achieved using chiral nanomaterials to regulate ROS are reviewed. Finally, the key issues and future prospects of chiral nanomaterials in the regulation of ROS are discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.